Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Katie K. Spielbauer"'
Autor:
Andrew M. Breglio, Aaron E. Rusheen, Eric D. Shide, Katharine A. Fernandez, Katie K. Spielbauer, Katherine M. McLachlin, Matthew D. Hall, Lauren Amable, Lisa L. Cunningham
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-9 (2017)
Permanent hearing loss occurs in many cancer patients treated with cisplatin. In this study, the authors examine cisplatin pharmacokinetics in the cochleae of mice and humans showing that cisplatin is retained for months to years after treatment.
Externí odkaz:
https://doaj.org/article/654bf441556b449db69facaa3c80c8f7
Autor:
Chitra, Subramanian, Katie K, Spielbauer, Robin, Pearce, Kevin J, Kovatch, Mark E, Prince, Barbara N, Timmermann, Mark S, Cohen
Publikováno v:
Nutrients; Volume 14; Issue 24; Pages: 5398
Treatment regimens for head and neck squamous cell carcinoma (HNSCC) typically include cisplatin and radiotherapy and are limited by toxicities. We have identified naturally derived withalongolide A triacetate (WGA-TA) from Physalis longifolia as a l
Autor:
Claire E Schaar, Dylan J Dues, Katie K Spielbauer, Emily Machiela, Jason F Cooper, Megan Senchuk, Siegfried Hekimi, Jeremy M Van Raamsdonk
Publikováno v:
PLoS Genetics, Vol 11, Iss 2, p e1004972 (2015)
Reactive oxygen species (ROS) are highly reactive, oxygen-containing molecules that can cause molecular damage within the cell. While the accumulation of ROS-mediated damage is widely believed to be one of the main causes of aging, ROS also act in si
Externí odkaz:
https://doaj.org/article/a434ee52eb734619b7a9cd5eacfefa8f
Autor:
Andrew J. Rosko, Chaz L. Stucken, Katie K. Spielbauer, Matthew E. Spector, Keith A. Casper, Jumin Sunde, Mark E. Prince, Steven B. Chinn, Kelly M. Malloy, Sathish S. Kumar, Samuel A. Schechtman, Marisa R. Buchakjian
Publikováno v:
Oral oncology. 124
Autor:
Jeremy M. Van Raamsdonk, Saravanapriah Nadarajan, Jason F. Cooper, Megan M. Senchuk, Monica P. Colaiácovo, Katie K. Spielbauer
Publikováno v:
Experimental Neurology. 310:58-69
Parkinson's disease (PD) is the second most common neurodegenerative disease and is characterized by the formation of α-synuclein-containing protein aggregates called Lewy bodies within the brain. A crucial role for α-synuclein in the pathogenesis
Autor:
Jeremy M. Van Raamsdonk, Dylan J. Dues, Megan M. Senchuk, Jason F. Cooper, Emily Machiela, Katie K. Spielbauer
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-16 (2017)
Scientific Reports
Scientific Reports
While the pathogenesis of Parkinson’s disease (PD) is incompletely understood, mitochondrial dysfunction is thought to play a crucial role in disease pathogenesis. Here, we examined the relationship between mitochondrial function and dopamine neuro
Autor:
Aaron E. Rusheen, Lizhen Wang, Katharine A. Fernandez, Lisa L. Cunningham, Stephen J. Eyles, Tiffany G. Baker, Katie K. Spielbauer
Publikováno v:
Hear Res
Cisplatin is used to treat a variety of solid tumors in both children and adults. However, cisplatin has serious side-effects, some of which may permanently affect patients' quality of life following treatment, such as ototoxicity. There is currently
Publikováno v:
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 159(2)
Immune checkpoint inhibition used in combination with standard cisplatin-based chemotherapy regimens is currently under evaluation in clinical trials for head and neck squamous cell carcinoma (HNSCC). The impact of anti–PD-1 therapy on cisplatin-in
Autor:
Aaron E. Rusheen, Katherine M. McLachlin, Katharine A. Fernandez, Andrew M. Breglio, Lauren Amable, Matthew D. Hall, Lisa L. Cunningham, Eric Shide, Katie K. Spielbauer
Publikováno v:
Nature Communications
Nature Communications, Vol 8, Iss 1, Pp 1-9 (2017)
Nature Communications, Vol 8, Iss 1, Pp 1-9 (2017)
Cisplatin chemotherapy causes permanent hearing loss in 40–80% of treated patients. It is unclear whether the cochlea has unique sensitivity to cisplatin or is exposed to higher levels of the drug. Here we use inductively coupled plasma mass spectr
Autor:
Ruth J. Davis, Carter Van Waes, So Jin Park, Ellen C. Moore, Katie K. Spielbauer, Nicole C. Schmitt, Linda Tran, Clint T. Allen, Roy Xiao
Publikováno v:
Cancer immunology research. 5(12)
Head and neck squamous cell carcinoma (HNSCC) has been treated for decades with cisplatin chemotherapy, and anti–PD-1 immunotherapy has recently been approved for the treatment of this disease. However, preclinical studies of how antitumor immunity